Abstract 2128P
Background
Exercise (EX) is associated with a reduction in mortality and recurrence risk in patients (pts) with cancer and may help pts cope with treatment side effects and improve their quality of life. This study aims to explore the role of oncologists in promoting exercise in the oncological context.
Methods
A self-administered, anonymous questionnaire was proposed to pts visiting the outpatients’ facilities at the Oncology Unit of Verona Hospital. The questionnaire assessed demographic, health, and EX parameters. EX variables, drawn from a prior study, included: the level evaluated with Godin’s Leisure Time Exercise Questionnaire and information regarding: whether EX was discussed; whether oncologists assess, advise, reinforce, and refer (AARR process) pts effort to exercising; and whether pts preferred that EX be discussed. Descriptive statistic, presented as mean, frequencies, and percentages, was applied.
Results
Overall, 202 pts completed the survey (76% response rate). The most frequent tumor types were upper gastrointestinal (45%) and breast (19%). Only 9% of pts were sufficiently active. Regarding the actual EX discussion, 29% of pts reported that their oncologist started a discussion about EX, 12% initiated the discussion themselves, and 60% referred that the issue was not considered. Concerning the AARR process, 26% of pts declared that their oncologists assessed their EX level, 14% and 33% received advice or reinforcement to increase their EX, respectively, and 9% were referred to an appropriate EX service. On the other hand, the items related to the preferred modality of EX discussion showed that 69% of pts thought that oncologists should initiate an EX-discussion, 3% that only pts should start the discussion, and 23% thought that EX should not be discussed.
Conclusions
Our preliminary results show that most pts are insufficiently active, and the majority stated that they did not discuss EX. Nevertheless, most pts would prefer that oncologists initiate a discussion about EX. According to these findings, strategies to support clinicians in promoting EX to their pts should be developed. Further pts’ enrollment is currently ongoing and a more updated analysis will be available for presentation at the ESMO Congress.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2125P - Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study
Presenter: Alessio Cortellini
Session: Poster session 06
2126P - Exercise implementation into a clinic setting with 1.660 cancer patients: Real-world data from eight years oncological exercise therapy in Cologne (OTT)
Presenter: Timo Niels
Session: Poster session 06
2127P - Long-term yoga reduces the side effects of systemic therapies and improves arm symptoms in the breast cancer patients
Presenter: Mayank Jain
Session: Poster session 06
2129P - Feasibility of a virtual exercise program to mitigate decline in physical function for advanced lung cancer patients
Presenter: Ying Wang, Sarah Yeo
Session: Poster session 06